It was very good. Key focus for next year is hitting hard on the diagnostics which is a huge market opportunity. Even if we get 0.5% market share it’s huge numbers. Company also focusing on executing some other long projects in tracing and authentication of various sectors. All in all great position. If they execute the strategy in the covid testing we would be very very happy holders!
It was very good. Key focus for next year is hitting hard on the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
